NV

Nathalie Vergnolle

CN CNRS: 2 patents #1,756 of 11,908Top 15%
IA Institut National De La Recherche Agronomqiue: 2 patents #67 of 760Top 9%
US Universite Toulouse Iii—Paul Sabatier: 2 patents #2 of 58Top 4%
U7 Université Paris Diderot—Paris 7: 1 patents #80 of 323Top 25%
Overall (All Time): #1,129,677 of 4,157,543Top 30%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11692045 Method of treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or gluten hypersensitivity by administering an elastase 2A (ELA2A) inhibitor Corinne Rolland, Céline Deraison-Manuel 2023-07-04
10829563 Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor Corinne Rolland, Céline Deraison-Manuel 2020-11-10
9688742 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) Jean-Michel Sallenave, Philippe Langella, Luis Bermudez-Humaran 2017-06-27
9125861 PAR2 agonists for use in the treatment or prevention of influenza virus type A infections Béatrice Riteau 2015-09-08